SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Cytrx Corp – ‘10-K’ for 12/31/13 – ‘EX-101.SCH’

On:  Tuesday, 3/4/14, at 6:18pm ET   ·   As of:  3/5/14   ·   For:  12/31/13   ·   Accession #:  799698-14-4   ·   File #:  0-15327

Previous ‘10-K’:  ‘10-K’ on 3/11/13 for 12/31/12   ·   Next:  ‘10-K’ on 3/10/15 for 12/31/14   ·   Latest:  ‘10-K’ on 3/27/24 for 12/31/23

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 3/05/14  Cytrx Corp                        10-K       12/31/13   77:9.7M

Annual Report   —   Form 10-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Form 10-K for Fiscal Year Ending 12/31/2013         HTML   1.30M 
 2: EX-4.8      Instrument Defining the Rights of Security Holders  HTML     46K 
 3: EX-10.22    Material Contract                                   HTML     68K 
 4: EX-10.23    Material Contract                                   HTML     53K 
 5: EX-10.24    Material Contract                                   HTML     53K 
 6: EX-10.25    Material Contract                                   HTML     52K 
 7: EX-10.29    Material Contract                                   HTML     24K 
 8: EX-10.30    Material Contract                                   HTML     24K 
 9: EX-10.31    Material Contract                                   HTML     24K 
10: EX-10.32    Material Contract                                   HTML     26K 
11: EX-23.1     Consent of Experts or Counsel                       HTML     22K 
12: EX-31.1     Certification -- §302 - SOA'02                      HTML     26K 
13: EX-31.2     Certification -- §302 - SOA'02                      HTML     26K 
14: EX-32.1     Certification -- §906 - SOA'02                      HTML     22K 
15: EX-32.2     Certification -- §906 - SOA'02                      HTML     22K 
54: R1          Document and Entity Information                     HTML     49K 
44: R2          Consolidated Balance Sheets                         HTML     95K 
52: R3          Consolidated Balance Sheets (Parenthetical)         HTML     48K 
56: R4          Consolidated Statements of Operations               HTML     70K 
72: R5          Consolidated Statements of Stockholders' Equity     HTML     71K 
46: R6          Consolidated Statements of Cash Flows               HTML    116K 
51: R7          Nature of Business                                  HTML     28K 
41: R8          Summary of Significant Accounting Policies          HTML     71K 
33: R9          Receivables                                         HTML     26K 
73: R10         Prepaid and Other Assets                            HTML     23K 
58: R11         Short-term Investments                              HTML     27K 
57: R12         Equipment and Furnishings                           HTML     31K 
62: R13         Accrued Expenses and Other Current Liabilities      HTML     31K 
63: R14         Warrant Liabilities                                 HTML     36K 
61: R15         Commitments and Contingencies                       HTML     51K 
64: R16         Equity Transactions                                 HTML     33K 
53: R17         Investments in ADVENTRX Pharmaceuticals             HTML     26K 
55: R18         Stock Options and Warrants                          HTML    221K 
60: R19         Sale of Assets                                      HTML     23K 
77: R20         Stockholder Protection Rights Plan                  HTML     25K 
67: R21         Income Taxes                                        HTML     58K 
48: R22         Quarterly Financial Data (Unaudited)                HTML     48K 
59: R23         Subsequent Events                                   HTML     59K 
50: R24         Schedule Ii - Valuation and Qualifying Accounts     HTML     40K 
27: R25         Summary of Significant Accounting Policies          HTML    124K 
                (Policies)                                                       
68: R26         Summary of Significant Accounting Policies          HTML     47K 
                (Tables)                                                         
74: R27         Equipment and Furnishings (Tables)                  HTML     29K 
37: R28         Accrued Expenses and Other Current Liabilities      HTML     30K 
                (Tables)                                                         
36: R29         Warrant Liabilities (Tables)                        HTML     34K 
39: R30         Commitments and Contingencies (Tables)              HTML     45K 
40: R31         Stock Options and Warrants (Tables)                 HTML    218K 
42: R32         Income Taxes (Tables)                               HTML     53K 
26: R33         Quarterly Financial Data (Unaudited) (Tables)       HTML     46K 
65: R34         Subsequent Events (Tables)                          HTML     58K 
47: R35         Nature of Business (Details)                        HTML     40K 
49: R36         Summary of Significant Accounting Policies          HTML     67K 
                (Details)                                                        
30: R37         Receivables (Details)                               HTML     23K 
76: R38         Prepaid and Other Assets (Details)                  HTML     23K 
22: R39         Short-term Investments (Details)                    HTML     26K 
43: R40         Equipment and Furnishings (Details)                 HTML     34K 
71: R41         Accrued Expenses and Other Current Liabilities      HTML     35K 
                (Details)                                                        
29: R42         Warrant Liabilities (Details)                       HTML     41K 
35: R43         Commitments and Contingencies (Details)             HTML     83K 
38: R44         Equity Transactions (Details)                       HTML     49K 
45: R45         Investments in ADVENTRX Pharmaceuticals (Details)   HTML     32K 
25: R46         Stock Options and Warrants (Details)                HTML    304K 
32: R47         Sale of Assets (Details)                            HTML     24K 
23: R48         Stockholder Protection Rights Plan (Details)        HTML     33K 
70: R49         Income Taxes (Details)                              HTML     96K 
28: R50         Quarterly Financial Data (Unaudited) (Details)      HTML     37K 
66: R51         Subsequent Events (Details)                         HTML     87K 
31: R52         Schedule Ii - Valuation and Qualifying Accounts     HTML     32K 
                (Details)                                                        
75: XML         IDEA XML File -- Filing Summary                      XML    100K 
24: EXCEL       IDEA Workbook of Financial Reports                  XLSX    171K 
34: EXCEL       IDEA Workbook of Financial Reports (.xls)            XLS   1.26M 
16: EX-101.INS  XBRL Instance -- cytr-20131231                       XML   1.91M 
18: EX-101.CAL  XBRL Calculations -- cytr-20131231_cal               XML    190K 
19: EX-101.DEF  XBRL Definitions -- cytr-20131231_def                XML    469K 
20: EX-101.LAB  XBRL Labels -- cytr-20131231_lab                     XML   1.57M 
21: EX-101.PRE  XBRL Presentations -- cytr-20131231_pre              XML    873K 
17: EX-101.SCH  XBRL Schema -- cytr-20131231                         XSD    162K 
69: ZIP         XBRL Zipped Folder -- 0000799698-14-000004-xbrl      Zip    166K 


‘EX-101.SCH’   —   XBRL Schema — cytr-20131231


This Exhibit is an XBRL XML File.


                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<!-- Generated by Disclosure Solutions PROFILE 2.5.2.1 Copyright 1995 - 2013 Thomson Reuters Accelus. All rights reserved. -->
<xs:schema targetNamespace="http://cytrx.com/20131231" elementFormDefault="qualified" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:cytr="http://cytrx.com/20131231" xmlns:us-types="http://fasb.org/us-types/2013-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:dei="http://xbrl.sec.gov/dei/2013-01-31">
<xs:annotation>
<xs:appinfo>
<link:linkbaseRef xlink:type="simple" xlink:href="cytr-20131231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
<link:linkbaseRef xlink:type="simple" xlink:href="cytr-20131231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
<link:linkbaseRef xlink:type="simple" xlink:href="cytr-20131231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
<link:linkbaseRef xlink:type="simple" xlink:href="cytr-20131231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
<link:roleType roleURI="http://cytrx.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
<link:definition> 000100 - Document - Document and Entity Information </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/ConsolidatedBalanceSheets" id="ConsolidatedBalanceSheets">
<link:definition> 010000 - Statement - CONSOLIDATED BALANCE SHEETS </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/ConsolidatedBalanceSheetsParenthetical" id="ConsolidatedBalanceSheetsParenthetical"> <!-- Parent Role: CONSOLIDATED BALANCE SHEETS -->
<link:definition> 010100 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/ConsolidatedStatementsOfOperations" id="ConsolidatedStatementsOfOperations">
<link:definition> 020000 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/ConsolidatedStatementsOfStockholdersEquity" id="ConsolidatedStatementsOfStockholdersEquity">
<link:definition> 030000 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/ConsolidatedStatementsOfCashFlows" id="ConsolidatedStatementsOfCashFlows">
<link:definition> 040000 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/NatureOfBusiness" id="NatureOfBusiness">
<link:definition> 060100 - Disclosure - Nature of Business </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/SummaryOfSignificantAccountingPolicies" id="SummaryOfSignificantAccountingPolicies">
<link:definition> 060200 - Disclosure - Summary of Significant Accounting Policies </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/Receivables" id="Receivables">
<link:definition> 060300 - Disclosure - Receivables </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/PrepaidAndOtherAssets" id="PrepaidAndOtherAssets">
<link:definition> 060400 - Disclosure - Prepaid and Other Assets </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/ShorttermInvestments" id="ShorttermInvestments">
<link:definition> 060500 - Disclosure - Short-term Investments </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/EquipmentAndFurnishings" id="EquipmentAndFurnishings">
<link:definition> 060600 - Disclosure - Equipment and Furnishings </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/AccruedExpensesAndOtherCurrentLiabilities" id="AccruedExpensesAndOtherCurrentLiabilities">
<link:definition> 060700 - Disclosure - Accrued Expenses and Other Current Liabilities </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/WarrantLiabilities" id="WarrantLiabilities">
<link:definition> 060800 - Disclosure - Warrant Liabilities </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
<link:definition> 060900 - Disclosure - Commitments and Contingencies </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/EquityTransactions" id="EquityTransactions">
<link:definition> 061000 - Disclosure - Equity Transactions </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/InvestmentsInAdventrxPharmaceuticals" id="InvestmentsInAdventrxPharmaceuticals">
<link:definition> 061100 - Disclosure - Investments in ADVENTRX Pharmaceuticals </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/StockOptionsAndWarrants" id="StockOptionsAndWarrants">
<link:definition> 061200 - Disclosure - Stock Options and Warrants </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/SaleOfAssets" id="SaleOfAssets">
<link:definition> 061300 - Disclosure - Sale of Assets </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/StockholderProtectionRightsPlan" id="StockholderProtectionRightsPlan">
<link:definition> 061400 - Disclosure - Stockholder Protection Rights Plan </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/IncomeTaxes" id="IncomeTaxes">
<link:definition> 061500 - Disclosure - Income Taxes </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/QuarterlyFinancialDataUnaudited" id="QuarterlyFinancialDataUnaudited">
<link:definition> 061600 - Disclosure - Quarterly Financial Data (unaudited) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/SubsequentEvents" id="SubsequentEvents">
<link:definition> 061700 - Disclosure - Subsequent Events </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/ScheduleIiValuationAndQualifyingAccounts" id="ScheduleIiValuationAndQualifyingAccounts">
<link:definition> 061800 - Schedule - SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/SummaryOfSignificantAccountingPoliciesPolicies" id="SummaryOfSignificantAccountingPoliciesPolicies"> <!-- Parent Role: Summary of Significant Accounting Policies -->
<link:definition> 070200 - Disclosure - Summary of Significant Accounting Policies (Policies) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/SummaryOfSignificantAccountingPoliciesTables" id="SummaryOfSignificantAccountingPoliciesTables"> <!-- Parent Role: Summary of Significant Accounting Policies -->
<link:definition> 080200 - Disclosure - Summary of Significant Accounting Policies (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/EquipmentAndFurnishingsTables" id="EquipmentAndFurnishingsTables"> <!-- Parent Role: Equipment and Furnishings -->
<link:definition> 080600 - Disclosure - Equipment and Furnishings (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/AccruedExpensesAndOtherCurrentLiabilitiesTables" id="AccruedExpensesAndOtherCurrentLiabilitiesTables"> <!-- Parent Role: Accrued Expenses and Other Current Liabilities -->
<link:definition> 080700 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/WarrantLiabilitiesTables" id="WarrantLiabilitiesTables"> <!-- Parent Role: Warrant Liabilities -->
<link:definition> 080800 - Disclosure - Warrant Liabilities (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/CommitmentsAndContingenciesTables" id="CommitmentsAndContingenciesTables"> <!-- Parent Role: Commitments and Contingencies -->
<link:definition> 080900 - Disclosure - Commitments and Contingencies (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/StockOptionsAndWarrantsTables" id="StockOptionsAndWarrantsTables"> <!-- Parent Role: Stock Options and Warrants -->
<link:definition> 081200 - Disclosure - Stock Options and Warrants (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/IncomeTaxesTables" id="IncomeTaxesTables"> <!-- Parent Role: Income Taxes -->
<link:definition> 081500 - Disclosure - Income Taxes (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/QuarterlyFinancialDataUnauditedTables" id="QuarterlyFinancialDataUnauditedTables"> <!-- Parent Role: Quarterly Financial Data (unaudited) -->
<link:definition> 081600 - Disclosure - Quarterly Financial Data (unaudited) (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/SubsequentEventsTables" id="SubsequentEventsTables"> <!-- Parent Role: Subsequent Events -->
<link:definition> 081700 - Disclosure - Subsequent Events (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/NatureOfBusinessDetails" id="NatureOfBusinessDetails"> <!-- Parent Role: Nature of Business -->
<link:definition> 090100 - Disclosure - Nature of Business (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/SummaryOfSignificantAccountingPoliciesDetails" id="SummaryOfSignificantAccountingPoliciesDetails"> <!-- Parent Role: Summary of Significant Accounting Policies -->
<link:definition> 090200 - Disclosure - Summary of Significant Accounting Policies (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/ReceivablesDetails" id="ReceivablesDetails"> <!-- Parent Role: Receivables -->
<link:definition> 090300 - Disclosure - Receivables (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/PrepaidAndOtherAssetsDetails" id="PrepaidAndOtherAssetsDetails"> <!-- Parent Role: Prepaid and Other Assets -->
<link:definition> 090400 - Disclosure - Prepaid and Other Assets (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/ShorttermInvestmentsDetails" id="ShorttermInvestmentsDetails"> <!-- Parent Role: Short-term Investments -->
<link:definition> 090500 - Disclosure - Short-term Investments (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/EquipmentAndFurnishingsDetails" id="EquipmentAndFurnishingsDetails"> <!-- Parent Role: Equipment and Furnishings -->
<link:definition> 090600 - Disclosure - Equipment and Furnishings (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/AccruedExpensesAndOtherCurrentLiabilitiesDetails" id="AccruedExpensesAndOtherCurrentLiabilitiesDetails"> <!-- Parent Role: Accrued Expenses and Other Current Liabilities -->
<link:definition> 090700 - Disclosure - Accrued Expenses and Other Current Liabilities (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/WarrantLiabilitiesDetails" id="WarrantLiabilitiesDetails"> <!-- Parent Role: Warrant Liabilities -->
<link:definition> 090800 - Disclosure - Warrant Liabilities (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/CommitmentsAndContingenciesDetails" id="CommitmentsAndContingenciesDetails"> <!-- Parent Role: Commitments and Contingencies -->
<link:definition> 090900 - Disclosure - Commitments and Contingencies (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/CommitmentsAndContingenciesDetailsCalc01" id="CommitmentsAndContingenciesDetailsCalc01"> <!-- Parent Role: Commitments and Contingencies (Details) -->
<link:definition> 090902 - Disclosure - Commitments and Contingencies (Details) CALC 01 </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/EquityTransactionsDetails" id="EquityTransactionsDetails"> <!-- Parent Role: Equity Transactions -->
<link:definition> 091000 - Disclosure - Equity Transactions (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/InvestmentsInAdventrxPharmaceuticalsDetails" id="InvestmentsInAdventrxPharmaceuticalsDetails"> <!-- Parent Role: Investments in ADVENTRX Pharmaceuticals -->
<link:definition> 091100 - Disclosure - Investments in ADVENTRX Pharmaceuticals (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/StockOptionsAndWarrantsDetails" id="StockOptionsAndWarrantsDetails"> <!-- Parent Role: Stock Options and Warrants -->
<link:definition> 091200 - Disclosure - Stock Options and Warrants (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/SaleOfAssetsDetails" id="SaleOfAssetsDetails"> <!-- Parent Role: Sale of Assets -->
<link:definition> 091300 - Disclosure - Sale of Assets (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/StockholderProtectionRightsPlanDetails" id="StockholderProtectionRightsPlanDetails"> <!-- Parent Role: Stockholder Protection Rights Plan -->
<link:definition> 091400 - Disclosure - Stockholder Protection Rights Plan (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/IncomeTaxesDetails" id="IncomeTaxesDetails"> <!-- Parent Role: Income Taxes -->
<link:definition> 091500 - Disclosure - Income Taxes (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/QuarterlyFinancialDataUnauditedDetails" id="QuarterlyFinancialDataUnauditedDetails"> <!-- Parent Role: Quarterly Financial Data (unaudited) -->
<link:definition> 091600 - Disclosure - Quarterly Financial Data (unaudited) (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/SubsequentEventsDetails" id="SubsequentEventsDetails"> <!-- Parent Role: Subsequent Events -->
<link:definition> 091700 - Disclosure - Subsequent Events (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cytrx.com/role/ScheduleIiValuationAndQualifyingAccountsDetails" id="ScheduleIiValuationAndQualifyingAccountsDetails"> <!-- Parent Role: SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS -->
<link:definition> 091800 - Schedule - SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
</xs:appinfo>
</xs:annotation>
<xs:import namespace="http://fasb.org/us-gaap/2013-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd"/>
<xs:import namespace="http://xbrl.sec.gov/dei/2013-01-31" schemaLocation="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd"/>
<xs:import namespace="http://xbrl.sec.gov/invest/2013-01-31" schemaLocation="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd"/>
<xs:import namespace="http://xbrl.sec.gov/country/2013-01-31" schemaLocation="http://xbrl.sec.gov/country/2013/country-2013-01-31.xsd"/>
<xs:import namespace="http://xbrl.sec.gov/currency/2012-01-31" schemaLocation="http://xbrl.sec.gov/currency/2012/currency-2012-01-31.xsd"/>
<xs:import namespace="http://xbrl.sec.gov/exch/2013-01-31" schemaLocation="http://xbrl.sec.gov/exch/2013/exch-2013-01-31.xsd"/>
<xs:import namespace="http://xbrl.sec.gov/naics/2011-01-31" schemaLocation="http://xbrl.sec.gov/naics/2011/naics-2011-01-31.xsd"/>
<xs:import namespace="http://xbrl.sec.gov/sic/2011-01-31" schemaLocation="http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd"/>
<xs:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>
<xs:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd"/>
<xs:import namespace="http://xbrl.sec.gov/stpr/2011-01-31" schemaLocation="http://xbrl.sec.gov/stpr/2011/stpr-2011-01-31.xsd"/>
<xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
<xs:import namespace="http://www.xbrl.org/2004/ref" schemaLocation="http://www.xbrl.org/2004/ref-2004-08-10.xsd"/>
<xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
<xs:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
<xs:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
<xs:import namespace="http://fasb.org/us-types/2013-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2013/elts/us-types-2013-01-31.xsd"/>
<xs:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd"/>
<xs:element name="EmploymentAgreementsFutureCashPaymentsDueAbstract" id="cytr_EmploymentAgreementsFutureCashPaymentsDueAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration"/>
<xs:element name="OperatingLeasesAndEmploymentAgreementsFutureMinimumPaymentsDueAbstract" id="cytr_OperatingLeasesAndEmploymentAgreementsFutureMinimumPaymentsDueAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration"/>
<xs:element name="OperatingLeasesFutureCashPaymentsDueAbstract" id="cytr_OperatingLeasesFutureCashPaymentsDueAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration"/>
<xs:element name="OperatingLeasesAndEmploymentAgreementsFutureMinimumPaymentsDueInFourYears" id="cytr_OperatingLeasesAndEmploymentAgreementsFutureMinimumPaymentsDueInFourYears" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit"/>
<xs:element name="SubTotalsFutureCashPaymentsDueAbstract" id="cytr_SubTotalsFutureCashPaymentsDueAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration"/>
<xs:element name="OperatingLeasesAndEmploymentAgreementsFutureMinimumPaymentsDueCurrent" id="cytr_OperatingLeasesAndEmploymentAgreementsFutureMinimumPaymentsDueCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit"/>
<xs:element name="OperatingLeasesAndEmploymentAgreementsFutureMinimumPaymentsDueInThreeYears" id="cytr_OperatingLeasesAndEmploymentAgreementsFutureMinimumPaymentsDueInThreeYears" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit"/>
<xs:element name="OperatingLeasesAndEmploymentAgreementsFutureMinimumPaymentsDue" id="cytr_OperatingLeasesAndEmploymentAgreementsFutureMinimumPaymentsDue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit"/>
<xs:element name="OperatingLeasesAndEmploymentAgreementsFutureMinimumPaymentsDueInTwoYears" id="cytr_OperatingLeasesAndEmploymentAgreementsFutureMinimumPaymentsDueInTwoYears" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit"/>
<xs:element name="ResearchAndDevelopmentFutureCashPaymentsDueAbstract" id="cytr_ResearchAndDevelopmentFutureCashPaymentsDueAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration"/>
<xs:element name="ResearchAndDevelopmentFutureMinimumPaymentsDue" id="cytr_ResearchAndDevelopmentFutureMinimumPaymentsDue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit"/>
<xs:element name="ResearchAndDevelopmentFutureMinimumPaymentsDueInThreeYears" id="cytr_ResearchAndDevelopmentFutureMinimumPaymentsDueInThreeYears" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit"/>
<xs:element name="ResearchAndDevelopmentFutureMinimumPaymentsDueCurrent" id="cytr_ResearchAndDevelopmentFutureMinimumPaymentsDueCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit"/>
<xs:element name="CommitmentAndContingenciesFutureMinimumPaymentsDueAbstract" id="cytr_CommitmentAndContingenciesFutureMinimumPaymentsDueAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration"/>
<xs:element name="ResearchAndDevelopmentFutureMinimumPaymentsDueInTwoYears" id="cytr_ResearchAndDevelopmentFutureMinimumPaymentsDueInTwoYears" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit"/>
<xs:element name="OperatingLeasesAndEmploymentAgreementsFutureMinimumPaymentsDueInFiveYears" id="cytr_OperatingLeasesAndEmploymentAgreementsFutureMinimumPaymentsDueInFiveYears" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit"/>
<xs:element name="ResearchAndDevelopmentFutureMinimumPaymentsDueInFourYears" id="cytr_ResearchAndDevelopmentFutureMinimumPaymentsDueInFourYears" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit"/>
<xs:element name="ResearchAndDevelopmentFutureMinimumPaymentsDueInFiveYears" id="cytr_ResearchAndDevelopmentFutureMinimumPaymentsDueInFiveYears" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit"/>
<xs:element name="WarrantsIssuedInConnectionWithFinancing" id="cytr_WarrantsIssuedInConnectionWithFinancing" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit"/>
<xs:element name="RepurchaseOfCommonStockPortionNotDisbursed" id="cytr_RepurchaseOfCommonStockPortionNotDisbursed" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit"/>
<xs:element name="WarrantLiabilitiesAbstract" id="cytr_WarrantLiabilitiesAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration"/>
<xs:element name="WarrantLiabilitiesTextBlock" id="cytr_WarrantLiabilitiesTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration"/>
<xs:element name="ChangesInCarryingAmountsOfWarrantLiabilitiesTableTextBlock" id="cytr_ChangesInCarryingAmountsOfWarrantLiabilitiesTableTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration"/>
<xs:element name="OtherIncomePolicyTextBlock" id="cytr_OtherIncomePolicyTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration"/>
<xs:element name="BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock" id="cytr_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration"/>
<xs:element name="ReverseStockSplitPolicyTextBlock" id="cytr_ReverseStockSplitPolicyTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration"/>
<xs:element name="WarrantLiabilitiesPolicyTextBlock" id="cytr_WarrantLiabilitiesPolicyTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration"/>
<xs:element name="PatentsAndPatentApplicationCostsPolicyTextBlock" id="cytr_PatentsAndPatentApplicationCostsPolicyTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration"/>
<xs:element name="ClinicalTrialExpensesPolicyTextBlock" id="cytr_ClinicalTrialExpensesPolicyTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration"/>
<xs:element name="SharesReservedForFutureIssuancePolicyTextBlock" id="cytr_SharesReservedForFutureIssuancePolicyTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration"/>
<xs:element name="ChangesInCarryingAmountsOfWarrantLiabilitiesAbstract" id="cytr_ChangesInCarryingAmountsOfWarrantLiabilitiesAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration"/>
<xs:element name="MaximumMaturityOfHighlyLiquidDebtInstrument" id="cytr_MaximumMaturityOfHighlyLiquidDebtInstrument" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration"/>
<xs:element name="WarrantLiabilityFairValueDisclosure" id="cytr_WarrantLiabilityFairValueDisclosure" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit"/>
<xs:element name="ShortTermInvestmentsFairValue" id="cytr_ShortTermInvestmentsFairValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit"/>
<xs:element name="MaximumMaturityToBeConsideredAsAvailableForSale" id="cytr_MaximumMaturityToBeConsideredAsAvailableForSale" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration"/>
<xs:element name="SeriesJuniorParticipatingPreferredStockSharesAuthorized" id="cytr_SeriesJuniorParticipatingPreferredStockSharesAuthorized" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant"/>
<xs:element name="AlbuminBindingCancerDrugsMember" id="cytr_AlbuminBindingCancerDrugsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration"/>
<xs:element name="NumberOfProgramsInClinicalDevelopmentForCancerIndications" id="cytr_NumberOfProgramsInClinicalDevelopmentForCancerIndications" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration"/>
<xs:element name="EstimatedProjectedExpendituresTypeTable" id="cytr_EstimatedProjectedExpendituresTypeTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" nillable="true" abstract="true" xbrli:periodType="duration"/>
<xs:element name="EstimatedProjectedExpenditureTypeLineItems" id="cytr_EstimatedProjectedExpenditureTypeLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration"/>
<xs:element name="ProjectedExpendituresForClinicalPrograms" id="cytr_ProjectedExpendituresForClinicalPrograms" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit"/>
<xs:element name="EstimatedProjectedExpendituresTypeAxis" id="cytr_EstimatedProjectedExpendituresTypeAxis" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" nillable="true" abstract="true" xbrli:periodType="duration"/>
<xs:element name="EstimatedProjectedExpenditureTypeDomain" id="cytr_EstimatedProjectedExpenditureTypeDomain" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration"/>
<xs:element name="OtherGeneralAndAdministrativeExpensesMember" id="cytr_OtherGeneralAndAdministrativeExpensesMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration"/>
<xs:element name="AldoxorubicinMember" id="cytr_AldoxorubicinMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration"/>
<xs:element name="GeneralOperationMember" id="cytr_GeneralOperationMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration"/>
<xs:element name="AvailableForSaleSecuritiesByMaturityDateAxis" id="cytr_AvailableForSaleSecuritiesByMaturityDateAxis" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" nillable="true" abstract="true" xbrli:periodType="duration"/>
<xs:element name="AvailableForSaleSecuritiesByMaturityDateDomain" id="cytr_AvailableForSaleSecuritiesByMaturityDateDomain" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration"/>
<xs:element name="MaturityDateTwoMemberMember" id="cytr_MaturityDateTwoMemberMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration"/>
<xs:element name="MaturityDateOneMemberMember" id="cytr_MaturityDateOneMemberMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration"/>
<xs:element name="MaturityDateThreeMemberMember" id="cytr_MaturityDateThreeMemberMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration"/>
<xs:element name="AccruedResearchAndDevelopmentCosts" id="cytr_AccruedResearchAndDevelopmentCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit"/>
<xs:element name="SalesOfAssetsAbstract" id="cytr_SalesOfAssetsAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration"/>
<xs:element name="SalesOfAssetsTextBlock" id="cytr_SalesOfAssetsTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration"/>
<xs:element name="LongTermIncentivePlanMember" id="cytr_LongTermIncentivePlanMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration"/>
<xs:element name="StockIncentivePlanMember" id="cytr_StockIncentivePlanMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration"/>
<xs:element name="ShareBasedCompensationAwardsByRecipientAxis" id="cytr_ShareBasedCompensationAwardsByRecipientAxis" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" nillable="true" abstract="true" xbrli:periodType="duration"/>
<xs:element name="ShareBasedCompensationAwardsByRecipientDomain" id="cytr_ShareBasedCompensationAwardsByRecipientDomain" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration"/>
<xs:element name="SeniorManagementMember" id="cytr_SeniorManagementMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration"/>
<xs:element name="EmployeesAndDirectorsMember" id="cytr_EmployeesAndDirectorsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration"/>
<xs:element name="EmployeesMember" id="cytr_EmployeesMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration"/>
<xs:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestOverSubsequentPeriod" id="cytr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestOverSubsequentPeriod" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant"/>
<xs:element name="CommonStockReservedAfterReverseSpiltForFutureIssuance" id="cytr_CommonStockReservedAfterReverseSpiltForFutureIssuance" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant"/>
<xs:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest" id="cytr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant"/>
<xs:element name="EstimatedAnnualizedForfeitureRate" id="cytr_EstimatedAnnualizedForfeitureRate" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration"/>
<xs:element name="ShareBasedCompensationOfUnvestedStockOptionsActivityAbstract" id="cytr_ShareBasedCompensationOfUnvestedStockOptionsActivityAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration"/>
<xs:element name="NumberOfUnvestedStockOptionsAbstract" id="cytr_NumberOfUnvestedStockOptionsAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration"/>
<xs:element name="WeightedAverageGrantDateFairValuePerShareAbstract" id="cytr_WeightedAverageGrantDateFairValuePerShareAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration"/>
<xs:element name="ShareBasedCompensationStockOptionsActivityAbstract" id="cytr_ShareBasedCompensationStockOptionsActivityAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration"/>
<xs:element name="ValueOfRestrictedSharesIssued" id="cytr_ValueOfRestrictedSharesIssued" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit"/>
<xs:element name="NumberOfOptionsAbstract" id="cytr_NumberOfOptionsAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration"/>
<xs:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodIntrinsicValue" id="cytr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodIntrinsicValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit"/>
<xs:element name="RangeOneMember" id="cytr_RangeOneMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration"/>
<xs:element name="RangeFiveMember" id="cytr_RangeFiveMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration"/>
<xs:element name="RangeEightMember" id="cytr_RangeEightMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration"/>
<xs:element name="RangeSixMember" id="cytr_RangeSixMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration"/>
<xs:element name="ShareBasedCompensationSharesAuthorizedUnderSignificantRangesOfOutstandingStockOptionPlansInPeriodAbstract" id="cytr_ShareBasedCompensationSharesAuthorizedUnderSignificantRangesOfOutstandingStockOptionPlansInPeriodAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration"/>
<xs:element name="RangeTwoMember" id="cytr_RangeTwoMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration"/>
<xs:element name="RangeSevenMember" id="cytr_RangeSevenMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration"/>
<xs:element name="RangeThreeMember" id="cytr_RangeThreeMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration"/>
<xs:element name="RangeFourMember" id="cytr_RangeFourMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration"/>
<xs:element name="NonEmployeesMember" id="cytr_NonEmployeesMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration"/>
<xs:element name="CommonStockSharePurchaseMaximum" id="cytr_CommonStockSharePurchaseMaximum" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration"/>
<xs:element name="WarrantsPerValue" id="cytr_WarrantsPerValue" type="num:perShareItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration"/>
<xs:element name="TaxCreditCarryforwardAmountAmt" id="cytr_TaxCreditCarryforwardAmountAmt" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit"/>
<xs:element name="PercentageOfDeferredTaxAssetsValuationAllowanceRecordedAgainstAssets" id="cytr_PercentageOfDeferredTaxAssetsValuationAllowanceRecordedAgainstAssets" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration"/>
<xs:element name="PercentageOfMarketValue" id="cytr_PercentageOfMarketValue" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration"/>
<xs:element name="OperatingLossCarryforwardsAnnually" id="cytr_OperatingLossCarryforwardsAnnually" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit"/>
<xs:element name="OperatingLossCarryforwardsRestricted" id="cytr_OperatingLossCarryforwardsRestricted" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit"/>
<xs:element name="TaxCreditCarryforwardAmountResearchAndDevelopment" id="cytr_TaxCreditCarryforwardAmountResearchAndDevelopment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit"/>
<xs:element name="PeriodOfTimeForNetOperatingLossLimitationsAfterOwnershipChange" id="cytr_PeriodOfTimeForNetOperatingLossLimitationsAfterOwnershipChange" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration"/>
<xs:element name="OperatingLossCarryforwardsUnrestricted" id="cytr_OperatingLossCarryforwardsUnrestricted" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit"/>
<xs:element name="IncomeTaxReconciliationWarrantyLiability" id="cytr_IncomeTaxReconciliationWarrantyLiability" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit"/>
<xs:element name="TaxCreditsCarryforwardExpirationDates" id="cytr_TaxCreditsCarryforwardExpirationDates" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration"/>
<xs:element name="CommonStockReceivedInAcquiringCompanyUponAcquisitionOfEquityMethodInvestee" id="cytr_CommonStockReceivedInAcquiringCompanyUponAcquisitionOfEquityMethodInvestee" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant"/>
<xs:element name="ProceedsFromSaleOfCommonStockInAcquiringEntity" id="cytr_ProceedsFromSaleOfCommonStockInAcquiringEntity" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit"/>
<xs:element name="AdditionalSharesOfCommonStockPotentiallyIssuableFromDevelopmentMilestonesMaximum" id="cytr_AdditionalSharesOfCommonStockPotentiallyIssuableFromDevelopmentMilestonesMaximum" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant"/>
<xs:element name="AdditionalSharesOfCommonStockHeldInEscrowPotentiallyIssuable" id="cytr_AdditionalSharesOfCommonStockHeldInEscrowPotentiallyIssuable" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant"/>
<xs:element name="AdventrxPharmaceuticalsMember" id="cytr_AdventrxPharmaceuticalsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration"/>
<xs:element name="SynthrxIncMember" id="cytr_SynthrxIncMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration"/>
<xs:element name="StockholderProtectionRightsPlanAbstract" id="cytr_StockholderProtectionRightsPlanAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration"/>
<xs:element name="StockholderProtectionRightsPlanTextBlock" id="cytr_StockholderProtectionRightsPlanTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration"/>
<xs:element name="BeneficialOwnershipPercentageOfCompanyOutstandingSharesOfCommonStockByAcquiringPerson" id="cytr_BeneficialOwnershipPercentageOfCompanyOutstandingSharesOfCommonStockByAcquiringPerson" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration"/>
<xs:element name="NumberOfBusinessDaysAfterAnnouncementRightsAreNotExercisableForCertainPersons" id="cytr_NumberOfBusinessDaysAfterAnnouncementRightsAreNotExercisableForCertainPersons" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration"/>
<xs:element name="ProportionOfRightEntitlesToPurchaseSeriesPreferredStock" id="cytr_ProportionOfRightEntitlesToPurchaseSeriesPreferredStock" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration"/>
<xs:element name="NumberOfRightForEachOutstandingShare" id="cytr_NumberOfRightForEachOutstandingShare" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration"/>
<xs:element name="PercentageOfCompanyOutstandingSharesOfCommonStockByAcquiringPerson" id="cytr_PercentageOfCompanyOutstandingSharesOfCommonStockByAcquiringPerson" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration"/>
<xs:element name="PeriodEntitledToPercentageBasedFeeFromAnyLicensingAgreement" id="cytr_PeriodEntitledToPercentageBasedFeeFromAnyLicensingAgreement" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration"/>
<xs:element name="DocumentAndEntityInformationAbstract" id="cytr_DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration"/>
<xs:element name="ScheduleOfWeightedAverageAssumptionsTableTextBlock" id="cytr_ScheduleOfWeightedAverageAssumptionsTableTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration"/>
<xs:element name="ScheduleOfSelectedProFormaBalanceSheetDataTableTextBlock" id="cytr_ScheduleOfSelectedProFormaBalanceSheetDataTableTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration"/>
</xs:schema>

Top
Filing Submission 0000799698-14-000004   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., Mar. 28, 5:51:14.1pm ET